History Of Cadiology

Home » Cancer

« Go Back

With EPA Review Underway, New Study Confirms Pesticide Chlorpyrifos is Linked to Childhood Developmental Delays

Exposure to the pesticide chlorpyrifos—which is banned for use in U.S. households but is still widely used throughout the agricultural industry—is associated with early childhood developmental delays, after controlling for community-level factors, according to a new study appearing in the American Journal of Public Health.

New Research Offers Hope In Fight Against Mesothelioma

Attorney Joseph W. Belluck of Belluck & Fox in New York, NY welcomes rare good news in efforts to cure asbestos-related cancer known as mesothelioma.

'Cancer Research' Has Published a Paper on the Activity of MM-121, an ErbB3 Inhibitor, in Ligand-dependent Tumors

Dana-Farber Cancer Institute, Massachusetts General Hospital Cancer Center, Dana-Farber/Harvard Cancer Center, Cell Signaling Technology, Harvard Medical School and Merrimack Pharmaceuticals collaborated on the MM-121 research. Researchers looked at MM-121 in combination with Erbitux to study efficacy in preclinical cancer models resistant to other targeted therapies.

BioDiscovery Releases Nexus Expression version 2 for Gene Regulation Analysis

BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Expression version 2 for gene expression analysis. Nexus Expression provides users an intuitive yet powerful interface for using gene expression results to associate sample attributes with gene annotations and biological processes. New features in version 2 make it even easier for users to load data with a one-click tool and to find relevant biological information.

Mesothelioma Victims Center Makes Finding The Best Mesothelioma Law Firms Easy For Mesothelioma Cancer Victims

The Mesothelioma Victims Center is saying, "it should not be complicated, or confusing for a individual looking for the names of some of the best actual mesothelioma law firms, or attorneys in the US--it should be simple. Our goal is to cut the middleman law firms out of the equation." Mesothelioma is a rare form of cancer related to exposure to asbestos. The Mesothelioma Victims Center was created to be the most helpful resource for individuals diagnosed with mesothelioma in the US. The group says, "this year we change the mesothelioma game played by many law firms--by giving mesothelioma victims, or their family members the names of some of the most capable mesothelioma trial law firms in the US. This way a mesothelioma victim, or their family does not have to try to go on the Internet, in an attempt to find the correct law firm." For more information please call the Mesothelioma Victims Center at 866-714-6466, or contact the group via its web site at Http://MesotheliomaVictimsCenter.Com

IQ Advanced Of San Diego Announces The Launch Of HarmfulAdditives.Com

iQ Advanced, an information marketing company whose mission is to raise awareness through intelligent information, announces the release of a free online consumer guide to harmful and toxic food additives. This Free online guide is the consumers’ resource to finding out what hazardous by-products and additives are present into everyday foods.

Ultra Marathoner Joins North American Seminars, Inc. Instructor Team with Introduction a of New Physical Therapy Continuing Education Course, Titled Running Injuries

North American Seminars Inc. introduces a new physical therapy continuing education course. Running Injuries - Examination, Differential Diagnosis and Treatment Interventions will be instructed by Jeff Taylor-Haas, PT, MPT, OCS, CSCSM

WARHEADS® Makes It Personal

WARHEADS partners with Hood Games and St. Baldrick’s Foundation

Breast Cancer Thought Leaders Differentiate Development Compounds in New MedPredict Report

MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report in its oncology series entitled “Thought Leader Insight & Analysis: Breast Cancer,” designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and treatments in this disease area.

Prevennia Supplement Blocks the Initiation of Breast Cell Mutations by Estrogens

Every 13 minutes a woman loses her battle with breast cancer and in 2009 alone more than 27,000 men died from prostate cancer. These powerful statistics continue to fuel research and new developments. With tens of millions of dollars in financial support from the National Cancer Institute and the U.S. Department of Defense, scientists have identified how estrogens can start the process leading to mutations in cells. In partnership with the scientists, Prevennia™ is a new dietary supplement, scientifically-proven and supported by 35 years of research, designed to block the estrogen-initiated triggering mechanism for breast mutations in cells.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 Next

Page 1 of 92